USD 0.1
(-0.45%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -4.86 Million CAD | -2.75% |
2022 | -4.79 Million CAD | -33.66% |
2021 | -3.7 Million CAD | -122.69% |
2020 | -1.56 Million CAD | 49.22% |
2019 | -3.13 Million CAD | 17.44% |
2018 | -3.79 Million CAD | -17.72% |
2017 | -3.65 Million CAD | -85.23% |
2016 | -2.17 Million CAD | 12.89% |
2015 | -1.83 Million CAD | 3.25% |
2014 | -2.06 Million CAD | 36.78% |
2013 | -3.26 Million CAD | 33.13% |
2012 | -4.88 Million CAD | -21.7% |
2011 | -4.01 Million CAD | -75.48% |
2010 | -2.28 Million CAD | -43.34% |
2009 | -1.59 Million CAD | 68.06% |
2008 | -4.99 Million CAD | -219.63% |
2007 | -1.56 Million CAD | -3621.58% |
2006 | -41.97 Thousand CAD | 59.47% |
2005 | -103.56 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -1.36 Million CAD | -17.62% |
2024 Q1 | -1.15 Million CAD | 4.77% |
2023 Q4 | -1.22 Million CAD | -8.0% |
2023 Q1 | -1.34 Million CAD | -30.25% |
2023 FY | - CAD | -2.75% |
2023 Q2 | -1.07 Million CAD | 20.08% |
2023 Q3 | -1.13 Million CAD | -5.32% |
2022 Q4 | -1.03 Million CAD | 27.03% |
2022 FY | - CAD | -33.66% |
2022 Q1 | -985.28 Thousand CAD | 13.73% |
2022 Q2 | -1.32 Million CAD | -33.99% |
2022 Q3 | -1.41 Million CAD | -7.34% |
2021 Q2 | -878.02 Thousand CAD | -9.56% |
2021 Q3 | -720.26 Thousand CAD | 17.97% |
2021 FY | - CAD | -122.69% |
2021 Q4 | -1.14 Million CAD | -58.56% |
2021 Q1 | -801.37 Thousand CAD | -59.91% |
2020 Q2 | -253.43 Thousand CAD | 24.56% |
2020 Q4 | -501.13 Thousand CAD | -0.25% |
2020 FY | - CAD | 49.22% |
2020 Q3 | -499.89 Thousand CAD | -97.25% |
2020 Q1 | -335.93 Thousand CAD | 42.81% |
2019 FY | - CAD | 17.44% |
2019 Q1 | -993.49 Thousand CAD | -6.39% |
2019 Q2 | -811.97 Thousand CAD | 18.27% |
2019 Q4 | -587.43 Thousand CAD | 20.49% |
2019 Q3 | -738.85 Thousand CAD | 9.0% |
2018 Q2 | -1.09 Million CAD | -22.78% |
2018 Q1 | -893.95 Thousand CAD | 4.94% |
2018 FY | - CAD | -17.72% |
2018 Q4 | -933.81 Thousand CAD | -7.59% |
2018 Q3 | -867.94 Thousand CAD | 20.92% |
2017 Q4 | -940.4 Thousand CAD | 18.48% |
2017 FY | - CAD | -85.23% |
2017 Q3 | -1.15 Million CAD | -71.47% |
2017 Q2 | -672.78 Thousand CAD | -40.84% |
2017 Q1 | -477.69 Thousand CAD | -385.85% |
2016 Q1 | -576.54 Thousand CAD | 8.29% |
2016 Q2 | -632.83 Thousand CAD | -9.76% |
2016 Q3 | -445.01 Thousand CAD | 29.68% |
2016 FY | - CAD | 12.89% |
2016 Q4 | -98.32 Thousand CAD | 77.91% |
2015 Q3 | -353.15 Thousand CAD | 28.4% |
2015 FY | - CAD | 3.25% |
2015 Q1 | -452.18 Thousand CAD | 41.04% |
2015 Q2 | -493.23 Thousand CAD | -9.08% |
2015 Q4 | -628.65 Thousand CAD | -78.01% |
2014 Q3 | -557.67 Thousand CAD | -39.99% |
2014 Q1 | -317.68 Thousand CAD | 66.66% |
2014 FY | - CAD | 36.78% |
2014 Q4 | -766.95 Thousand CAD | -37.53% |
2014 Q2 | -398.35 Thousand CAD | -25.39% |
2013 Q4 | -952.78 Thousand CAD | -22.94% |
2013 Q2 | -722.63 Thousand CAD | 11.29% |
2013 Q1 | -814.6 Thousand CAD | 43.16% |
2013 FY | - CAD | 33.13% |
2013 Q3 | -775.03 Thousand CAD | -7.25% |
2012 FY | - CAD | -21.7% |
2012 Q3 | -1.31 Million CAD | -24.63% |
2012 Q2 | -1.05 Million CAD | 6.17% |
2012 Q1 | -1.12 Million CAD | -20.77% |
2012 Q4 | -1.43 Million CAD | -8.88% |
2011 Q2 | -943.33 Thousand CAD | -13.38% |
2011 FY | - CAD | -75.48% |
2011 Q4 | -932.11 Thousand CAD | 12.2% |
2011 Q3 | -1.06 Million CAD | -12.54% |
2011 Q1 | -832 Thousand CAD | -14.5% |
2010 Q2 | -583.72 Thousand CAD | -175.94% |
2010 Q3 | -773.74 Thousand CAD | -32.55% |
2010 FY | - CAD | -43.34% |
2010 Q4 | -726.65 Thousand CAD | 6.09% |
2010 Q1 | -211.53 Thousand CAD | 49.89% |
2009 Q4 | -422.12 Thousand CAD | -89.03% |
2009 FY | - CAD | 68.06% |
2009 Q2 | -402.92 Thousand CAD | 41.06% |
2009 Q1 | -683.61 Thousand CAD | 61.81% |
2009 Q3 | -223.3 Thousand CAD | 44.58% |
2008 Q1 | -816.5 Thousand CAD | 1.3% |
2008 Q4 | -1.79 Million CAD | -45.99% |
2008 Q2 | -1.09 Million CAD | -33.84% |
2008 Q3 | -1.22 Million CAD | -12.2% |
2008 FY | - CAD | -219.63% |
2007 Q3 | -337.88 Thousand CAD | -5929.93% |
2007 Q4 | -827.25 Thousand CAD | -144.83% |
2007 FY | - CAD | -3621.58% |
2007 Q2 | -5603.53 CAD | 87.75% |
2007 Q1 | -45.72 Thousand CAD | -41.77% |
2006 Q1 | -9992.07 CAD | 0.0% |
2006 Q4 | -32.25 Thousand CAD | -1882.07% |
2006 Q3 | 1810.01 CAD | 217.97% |
2006 FY | - CAD | 59.47% |
2006 Q2 | -1534.25 CAD | 84.65% |
2005 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
BioElectronics Corporation | -274.29 Thousand USD | -1673.244% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 1166.489% |
Polarean Imaging plc | -11.19 Million USD | 56.554% |
Avitar, Inc. | -1.66 Million USD | -191.631% |
CVR Medical Corp. | - USD | Infinity% |
IR-Med Inc. | -4.89 Million USD | 0.576% |
AVITA Medical, Inc. | -39.56 Million USD | 87.708% |
Manhattan Scientifics, Inc. | -1.16 Million USD | -317.855% |
Össur hf. | 137.38 Million USD | 103.54% |
Zecotek Photonics Inc. | -3.44 Million USD | -41.299% |
QHSLab, Inc. | -91.29 Thousand USD | -5227.714% |
Wellstar International, Inc. | -1.35 Million USD | -258.553% |
Össur hf. | 137.38 Million USD | 103.54% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 149.762% |
Escalon Medical Corp. | -58.46 Thousand USD | -8219.786% |
Aurora Spine Corporation | -454.37 Thousand USD | -970.437% |
BrainsWay Ltd. | -2.31 Million USD | -110.464% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.37 Million USD | 48.143% |
Hamilton Thorne Ltd. | 5.52 Million USD | 188.087% |
Vivos Inc. | -2.79 Million USD | -74.134% |
MicroPort Scientific Corporation | -347.57 Million USD | 98.601% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -2360.319% |
REMSleep Holdings, Inc. | -1.66 Million USD | -191.5% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | -1183.651% |
Nanomix Corporation | -8.13 Million USD | 40.246% |
Theraclion SA | -2.05 Million USD | -137.169% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | -707.03 Thousand USD | -587.924% |
Positron Corporation | -1.45 Million USD | -234.94% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | -182.471% |
Lombard Medical, Inc. | -28.06 Million USD | 82.671% |
ALR Technologies Inc. | -6.4 Million USD | 24.006% |
Stratec SE | 39.91 Million USD | 112.186% |
Vycor Medical, Inc. | 100.94 Thousand USD | 4918.393% |
Heart Tronics, Inc. | -14.85 Million USD | 67.262% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -4012.862% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 63.366% |
SANUWAVE Health, Inc. | -9.15 Million USD | 46.855% |
VMS Rehab Systems, Inc. | -68.55 USD | -7095202.699% |
Guided Therapeutics, Inc. | -3.12 Million USD | -55.593% |
Ingen Technologies, Inc. | -8639.00 USD | -56200.845% |
Odyssey Group International, Inc. | -2.13 Million USD | -127.487% |
United American Healthcare Corporation | -59 Thousand USD | -8143.78% |
ECGI Holdings, Inc. | -2.99 Million USD | -62.646% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | -673.039% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -846.224% |
Urologix, Inc. | -6.34 Million USD | 23.332% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -292.447% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | -534.992% |
SS Innovations International, Inc. | -20.37 Million USD | 76.13% |
Qualis Innovations, Inc. | -222.81 Thousand USD | -2082.871% |
Smith & Nephew plc | 1 Billion USD | 100.485% |
NIOX Group Plc | 11.07 Million USD | 143.917% |
Fuse Medical, Inc. | 1.83 Million USD | 365.013% |
Broncus Holding Corporation | -25.19 Million USD | 80.698% |
Brain Scientific Inc. | -7.93 Million USD | 38.694% |
Pressure BioSciences, Inc. | -9.39 Million USD | 48.207% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -26333.859% |